Biomaterial-mediated immunomodulation of regulatory T cells in cancer
Biomaterials Science · 2026
DOI: 10.1039/d6bm00653a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2026. Verfasst von Autumn C Hengen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, Georgia Institute of Technology, Atlanta, GA, USA. ahen…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms, Biocompatible Materials, Immunomodulation. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Georgia Institute of Technology.
Abstract (Originalsprache)
Biomaterials enable selective modulation of regulatory T cells by targeting metabolic, transcriptional, and signaling pathways, offering new strategies to overcome tumor immunosuppression while preserving immune homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, Georgia Institute of Technology, Atlanta, GA, USA. ahengen3@gatech.edu.
- Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Förderung
- Georgia Institute of Technology
Zitieren
APA
Hengen, A. C., Kolon, H. H., & Ackun-Farmmer, M. A. (2026). Biomaterial-mediated immunomodulation of regulatory T cells in cancer. Biomaterials Science. https://doi.org/10.1039/d6bm00653a
Vancouver
Hengen AC, Kolon HH, Ackun-Farmmer MA. Biomaterial-mediated immunomodulation of regulatory T cells in cancer. Biomaterials Science. 2026. doi:10.1039/d6bm00653a
BibTeX
@article{Hengen2026,
author = {Hengen, Autumn C and Kolon, Helena H and Ackun-Farmmer, Marian A},
title = {Biomaterial-mediated immunomodulation of regulatory T cells in cancer},
journal = {Biomaterials Science},
year = {2026},
doi = {10.1039/d6bm00653a}
}
EUVIMED